表紙
市場調査レポート

米国:リキッドバイオプシー (液体生検) 検査市場 & 検査件数の分析 2020年

United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020

発行 Renub Research 商品コード 349638
出版日 ページ情報 英文 79 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
米国:リキッドバイオプシー (液体生検) 検査市場 & 検査件数の分析 2020年 United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020
出版日: 2016年01月12日 ページ情報: 英文 79 Pages
概要

当レポートでは、急成長を示す米国のリキッドバイオプシー (液体生検) 市場について包括的に調査し、米国の5大癌セグメントにおけるリキッドバイオプシー検査市場および件数の分析、近年の発展動向、主な契約、および市場の促進因子と課題について、まとめています。

第1章 エグゼクティブサマリー

第2章 米国:リキッドバイオプシー市場予測

  • リキッドバイオプシー市場
  • リキッドバイオプシースクリーニング検査市場
  • リキッドバイオプシー治療モニタリング市場

第3章 米国:リキッドバイオプシーの検査数予測

  • リキッドバイオプシー検査件数
  • リキッドバイオプシースクリーニング検査件数
  • リキッドバイオプシー治療モニタリング検査件数

第4章 米国:リキッドバイオプシー市場シェア予測

  • リキッドバイオプシー市場シェア:手法別
  • リキッドバイオプシースクリーニング市場シェア:癌種類別
  • リキッドバイオプシー治療モニタリング市場シェア:癌種類別

第5章 米国:リキッドバイオプシー市場 & 検査件数:癌種類別の予測

  • 肺癌におけるリキッドバイオプシー市場・検査件数
  • 肺癌
  • 乳癌
  • 大腸癌
  • 前立腺癌
  • 肝臓癌

第6章 米国:リキッドバイオプシースクリーニング市場 & 検査件数:癌種類別の予測

  • 肺癌
  • 乳癌
  • 大腸癌
  • 前立腺癌
  • 肝臓癌

第7章 米国:リキッドバイオプシー治療モニタリング市場 & 検査件数:癌種類別の予測

  • 肺癌
  • 乳癌
  • 大腸癌
  • 前立腺癌
  • 肝臓癌
  • その他の癌

第8章 リキッドバイオプシー市場:近年の発展動向

第9章 リキッドバイオプシー市場:主要契約の分析

第10章 リキッドバイオプシー市場:促進因子

  • リアルタイム評価、利便性および精度
  • 低侵襲生検技術の需要増加
  • 技術進歩・個別療法

第11章 リキッドバイオプシー市場:課題

図表

目次

Overview

Liquid Biopsy Tests are emerging as a viable alternative to traditional methods for cancer screening. A liquid biopsy is a new type of blood test that has the potential to transform cancer treatment. Using this methodology, physicians avoid the traditional surgical and needle biopsies they use to determine the existence of cancer in patients. In United States Liquid Biopsy market; Screening Test is likely to capture major chunk of the market compared to Monitoring Market. It is anticipated that Liquid Biopsy Testing will be more helpful for monitoring cancer treatment and status after diagnosis than in screening for a cancer that may be years or even decades in the making and not otherwise detectable.

United States - Liquid Biopsy Potential Screening Market Analysis: In the United States liquid biopsy screening market, prostate cancer is the most popular segment. Lung cancer liquid biopsy screening stands at the last spot.

United States - Liquid Biopsy Potential Treatment Monitoring Market Analysis: In the United States liquid biopsy treatment monitoring market, breast cancer is the leading segment. Liver cancer stands at the fifth spot.

Renub Research report titled “United States - Liquid Biopsy Potential Testing Market & Volume Analysis to 2020” provides a comprehensive assessment of the fast-evolving, high-growth of Liquid Biopsy Market. This 79 page report with 41 Figures analyses the United States Liquid Biopsy Test Market and Volume by 5 Top Cancer Segment, Recent developments, Major Deals along with the driving factors and challenges for Liquid Biopsy Market.

The United States Liquid Biopsy Potential Market has been analyzed from two view points

1. United States Liquid Biopsy Potential Screening Market & Test Volume (2015 - 2020)

The Top 5 Cancer Segments covered are:

  • 1. Lung Cancer
  • 2. Breast Cancer
  • 3. Colorectal Cancer
  • 4. Prostate Cancer
  • 5. Liver Cancer

2. United States Liquid Biopsy Potential Treatment Monitoring Market & Test Volume (2015 - 2020)

The Top 6 Cancer Segments covered are:

  • 1. Lung Cancer
  • 2. Breast Cancer
  • 3. Colorectal Cancer
  • 4. Prostate Cancer
  • 5. Liver Cancer
  • 6. Other Cancers

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. United States - Liquid Biopsy Potential Market (2015-2020)

  • 2.1. United States - Liquid Biopsy Potential Market
  • 2.2. United States - Liquid Biopsy Screening Potential Market
  • 2.3. United States - Liquid Biopsy Treatment Monitoring Potential Market

3. United States - Liquid Biopsy Potential Test Volume (2015-2020)

  • 3.1. United States - Liquid Biopsy Potential Test Volume
  • 3.2. United States - Liquid Biopsy Potential Screening Test Volume
  • 3.3. United States - Liquid Biopsy Potential Treatment Monitoring Test Volume

4. United States - Liquid Biopsy Potential Market Share (2015-2020)

  • 4.1. United States - Liquid Biopsy Potential Market Share by Method
  • 4.2. United States - Liquid Biopsy Screening Potential Market Share by Cancer Types
  • 4.3. United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types

5. United States - Liquid Biopsy Potential Market & Test Volume by Cancer Types (2015-2020)

  • 5.1. United States - Liquid Biopsy Lung Cancer Potential Market & Test Volume
    • 5.1.1. United States - Liquid Biopsy Lung Cancer Potential Market
    • 5.1.2. United States - Liquid Biopsy Lung Cancer Potential Test Volume
  • 5.2. United States - Liquid Biopsy Breast Cancer Potential Market & Test Volume
    • 5.2.1. United States - Liquid Biopsy Breast Cancer Potential Market
    • 5.2.2. United States - Liquid Biopsy Breast Cancer Potential Test Volume
  • 5.3. United States - Liquid Biopsy Colorectal Cancer Potential Market & Test Volume
    • 5.3.1. United States - Liquid Biopsy Colorectal Cancer Potential Market
    • 5.3.2. United States - Liquid Biopsy Colorectal Cancer Potential Test Volume
  • 5.4. United States - Liquid Biopsy Prostate Cancer Potential Market & Test Volume
    • 5.4.1. United States - Liquid Biopsy Prostate Cancer Potential Market
    • 5.4.2. United States - Liquid Biopsy Prostate Cancer Potential Test Volume
  • 5.5. United States - Liquid Biopsy Liver Cancer Potential Market & Test Volume
    • 5.5.1. United States - Liquid Biopsy Liver Cancer Potential Market
    • 5.5.2. United States - Liquid Biopsy Liver Cancer Potential Test Volume

6. United States - Liquid Biopsy Screening Potential Market & Test Volume by Cancer Types (2015-2020)

  • 6.1. United States - Liquid Biopsy Lung Cancer Screening Potential Market & Test Volume
    • 6.1.1. United States - Liquid Biopsy Lung Cancer Screening Potential Market
    • 6.1.2. United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume
  • 6.2. United States - Liquid Biopsy Breast Cancer Screening Potential Market & Test Volume
    • 6.2.1. United States - Liquid Biopsy Breast Cancer Screening Potential Market
    • 6.2.2. United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume
  • 6.3. United States - Liquid Biopsy Colorectal Cancer Screening Potential Market & Test Volume
    • 6.3.1. United States - Liquid Biopsy Colorectal Cancer Screening Potential Market
    • 6.3.2. United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume
  • 6.4. United States - Liquid Biopsy Prostate Cancer Screening Potential Market & Test Volume
    • 6.4.1. United States - Liquid Biopsy Prostate Cancer Screening Potential Market
    • 6.4.2. United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume
  • 6.5. United States - Liquid Biopsy Liver Cancer Screening Potential Market & Test Volume
    • 6.5.1. United States - Liquid Biopsy Liver Cancer Screening Potential Market
    • 6.5.2. United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume

7. United States - Liquid Biopsy Treatment Monitoring Potential Market & Test Volume by Cancer Types (2015-2020)

  • 7.1. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.1.1. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market
    • 7.1.2. United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume
  • 7.2. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.2.1. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market
    • 7.2.2. United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume
  • 7.3. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.3.1. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market
    • 7.3.2. United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume
  • 7.4. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.4.1. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market
    • 7.4.2. United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume
  • 7.5. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market & Test Volume
    • 7.5.1. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market
    • 7.5.2. United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume
  • 7.6. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market & Test Volume
    • 7.6.1. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market
    • 7.6.2. United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume

8. Liquid Biopsy Market-Recent Development

9. Liquid Biopsy Market-Major Deals Analysis

10. Liquid Biopsy Market-Driving Factors

  • 10.1. Real-Time Evaluation, Convenient and Accuracy
  • 10.2. Increasing Demand for Minimally-Invasive Biopsy Techniques
  • 10.3. Technical Advancement & Personalized Therapies

11. Liquid Biopsy Market-Challenges

  • 11.1. Barriers for Liquid Biopsies
    • 11.1.1. Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
    • 11.1.2. Low Concentration of Target DNA in A Plasma Sample
    • 11.1.3. Proper Handling and Storage of the Samples Critical

List of Figures:

  • Figure 2-1: United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020
  • Figure 2-2: United States - Liquid Biopsy Screening Potential Market (Million US$), 2015 - 2020
  • Figure 2-3: United States - Liquid Biopsy Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 3-1: United States - Liquid Biopsy Potential Test Volume (Number), 2015 - 2020
  • Figure 3-2: United States - Liquid Biopsy Potential Screening Test Volume (Number), 2015 - 2020
  • Figure 3-3: United States - Liquid Biopsy Potential Treatment Monitoring Test Volume (Number), 2015 - 2020
  • Figure 4-1: United States-Method Wise Liquid Biopsy Potential Market Share (Percent), 2015 - 2020
  • Figure 4-2: United States - Liquid Biopsy Screening Potential Market Share by Cancer Types (Percent), 2015 - 2020
  • Figure 4-3: United States - Liquid Biopsy Treatment Monitoring Potential Market Share by Cancer Types (Percent), 2015 - 2020
  • Figure 5-1: United States - Liquid Biopsy Lung Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-2: United States - Liquid Biopsy Lung Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-3: United States - Liquid Biopsy Breast Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-4: United States - Liquid Biopsy Breast Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-5: United States - Liquid Biopsy Colorectal Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-6: United States - Liquid Biopsy Colorectal Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-7: United States - Liquid Biopsy Prostate Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-8: United States - Liquid Biopsy Prostate Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 5-9: United States - Liquid Biopsy Liver Cancer Potential Market (Million US$), 2015 - 2020
  • Figure 5-10: United States - Liquid Biopsy Liver Cancer Potential Test Volume (Number), 2015 - 2020
  • Figure 6-1: United States - Liquid Biopsy Lung Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-2: United States - Liquid Biopsy Lung Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-3: United States - Liquid Biopsy Breast Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-4: United States - Liquid Biopsy Breast Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-5: United States - Liquid Biopsy Colorectal Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-6: United States - Liquid Biopsy Colorectal Cancer Screening Potential Test Volume (Number), 2015-2020
  • Figure 6-7: United States - Liquid Biopsy Prostate Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-8: United States - Liquid Biopsy Prostate Cancer Screening Potential Test Volume (Number), 2015 - 2020
  • Figure 6-9: United States - Liquid Biopsy Liver Cancer Screening Potential Market (Million US$), 2015 - 2020
  • Figure 6-10: United States - Liquid Biopsy Liver Cancer Screening Potential Test Volume (Number), 2015-2020
  • Figure 7-1: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-2: United States - Liquid Biopsy Lung Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-3: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-4: United States - Liquid Biopsy Breast Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-5: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-6: United States - Liquid Biopsy Colorectal Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-7: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-8: United States - Liquid Biopsy Prostate Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-9: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-10: United States - Liquid Biopsy Liver Cancer Treatment Monitoring Potential Test Volume (Number), 2015 - 2020
  • Figure 7-11: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Market (Million US$), 2015 - 2020
  • Figure 7-12: United States - Liquid Biopsy Other Cancers Treatment Monitoring Potential Test Volume (Number), 2015-2020
Back to Top